These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32080977)

  • 1. Computational-based discovery of FAK FERM domain chemical probes that inhibit HER2-FAK cancer signaling.
    Stahl E; Nott R; Koessel K; Cance W; Marlowe T
    Chem Biol Drug Des; 2020 Jun; 95(6):584-599. PubMed ID: 32080977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High resolution crystal structure of the FAK FERM domain reveals new insights on the Druggability of tyrosine 397 and the Src SH3 binding site.
    Marlowe T; Dementiev A; Figel S; Rivera A; Flavin M; Cance W
    BMC Mol Cell Biol; 2019 May; 20(1):10. PubMed ID: 31109284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic Receptor Tyrosine Kinases Directly Phosphorylate Focal Adhesion Kinase (FAK) as a Resistance Mechanism to FAK-Kinase Inhibitors.
    Marlowe TA; Lenzo FL; Figel SA; Grapes AT; Cance WG
    Mol Cancer Ther; 2016 Dec; 15(12):3028-3039. PubMed ID: 27638858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in the Development of Small Molecular Inhibitors of Focal Adhesion Kinase (FAK).
    Lu Y; Sun H
    J Med Chem; 2020 Dec; 63(23):14382-14403. PubMed ID: 33058670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FERM domain interaction promotes FAK signaling.
    Dunty JM; Gabarra-Niecko V; King ML; Ceccarelli DF; Eck MJ; Schaller MD
    Mol Cell Biol; 2004 Jun; 24(12):5353-68. PubMed ID: 15169899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of the FERM domain of focal adhesion kinase.
    Ceccarelli DF; Song HK; Poy F; Schaller MD; Eck MJ
    J Biol Chem; 2006 Jan; 281(1):252-9. PubMed ID: 16221668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The FERM domain: organizing the structure and function of FAK.
    Frame MC; Patel H; Serrels B; Lietha D; Eck MJ
    Nat Rev Mol Cell Biol; 2010 Nov; 11(11):802-14. PubMed ID: 20966971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Akt1 binds focal adhesion kinase via the Akt1 kinase domain independently of the pleckstrin homology domain.
    Basson MD; Zeng B; Wang S
    J Physiol Pharmacol; 2015 Oct; 66(5):701-9. PubMed ID: 26579576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal adhesion kinase (FAK) binds RET kinase via its FERM domain, priming a direct and reciprocal RET-FAK transactivation mechanism.
    Plaza-Menacho I; Morandi A; Mologni L; Boender P; Gambacorti-Passerini C; Magee AI; Hofstra RM; Knowles P; McDonald NQ; Isacke CM
    J Biol Chem; 2011 May; 286(19):17292-302. PubMed ID: 21454698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residues within the first subdomain of the FERM-like domain in focal adhesion kinase are important in its regulation.
    Cohen LA; Guan JL
    J Biol Chem; 2005 Mar; 280(9):8197-207. PubMed ID: 15611137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FERM domain interaction with myosin negatively regulates FAK in cardiomyocyte hypertrophy.
    Santos AM; Schechtman D; Cardoso AC; Clemente CF; Silva JC; Fioramonte M; Pereira MB; Marin TM; Oliveira PS; Figueira AC; Oliveira SH; Torriani ÍL; Gozzo FC; Xavier Neto J; Franchini KG
    Nat Chem Biol; 2011 Nov; 8(1):102-10. PubMed ID: 22101605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational insights into allosteric inhibition of focal adhesion kinase: A combined pharmacophore modeling and molecular dynamics approach.
    Kumar V; Singh P; Parate S; Singh R; Ro HS; Song KS; Lee KW; Park YM
    J Mol Graph Model; 2024 Jul; 130():108789. PubMed ID: 38718434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into FAK phosphorylation based on a FAT domain-defective mutation.
    Fang X; Liu X; Yao L; Chen C; Lin J; Ni P; Zheng X; Fan Q
    PLoS One; 2014; 9(9):e107134. PubMed ID: 25226367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Silico Screening to Identify Inhibitors of Growth Factor Receptor 2-Focal Adhesion Kinase Interaction for Therapeutic Treatment of Pathological Cardiac Hypertrophy.
    Mohanty P; Bhatnagar S
    Assay Drug Dev Technol; 2019; 17(2):58-67. PubMed ID: 30869527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting focal adhesion kinase (FAK) for cancer therapy: FAK inhibitors, FAK-based dual-target inhibitors and PROTAC degraders.
    Yang M; Xiang H; Luo G
    Biochem Pharmacol; 2024 Jun; 224():116246. PubMed ID: 38685282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic conformational changes in the FERM domain of FAK are involved in focal-adhesion behavior during cell spreading and motility.
    Papusheva E; Mello de Queiroz F; Dalous J; Han Y; Esposito A; Jares-Erijmanxa EA; Jovin TM; Bunt G
    J Cell Sci; 2009 Mar; 122(Pt 5):656-66. PubMed ID: 19208768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal transduction by focal adhesion kinase in cancer.
    Zhao J; Guan JL
    Cancer Metastasis Rev; 2009 Jun; 28(1-2):35-49. PubMed ID: 19169797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphatidylinositol 4,5-bisphosphate triggers activation of focal adhesion kinase by inducing clustering and conformational changes.
    Goñi GM; Epifano C; Boskovic J; Camacho-Artacho M; Zhou J; Bronowska A; Martín MT; Eck MJ; Kremer L; Gräter F; Gervasio FL; Perez-Moreno M; Lietha D
    Proc Natl Acad Sci U S A; 2014 Aug; 111(31):E3177-86. PubMed ID: 25049397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for the autoinhibition of focal adhesion kinase.
    Lietha D; Cai X; Ceccarelli DF; Li Y; Schaller MD; Eck MJ
    Cell; 2007 Jun; 129(6):1177-87. PubMed ID: 17574028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal adhesion kinase as a cancer therapy target.
    Golubovskaya VM
    Anticancer Agents Med Chem; 2010 Dec; 10(10):735-41. PubMed ID: 21214510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.